These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27363811)

  • 1. Polysaccharide Nanoparticles for Efficient siRNA Targeting in Cancer Cells by Supramolecular pKa Shift.
    Zhang YM; Yang Y; Zhang YH; Liu Y
    Sci Rep; 2016 Jul; 6():28848. PubMed ID: 27363811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
    Choi KM; Jang M; Kim JH; Ahn HJ
    Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
    Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
    Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer.
    Afkham A; Aghebati-Maleki L; Siahmansouri H; Sadreddini S; Ahmadi M; Dolati S; Afkham NM; Akbarzadeh P; Jadidi-Niaragh F; Younesi V; Yousefi M
    Pharmacol Rep; 2018 Jun; 70(3):418-425. PubMed ID: 29626645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulus-responsive drug/gene delivery system based on polyethylenimine cyclodextrin nanoparticles for potential cancer therapy.
    Mousazadeh H; Bonabi E; Zarghami N
    Carbohydr Polym; 2022 Jan; 276():118747. PubMed ID: 34823779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted polysaccharide nanoparticle for adamplatin prodrug delivery.
    Yang Y; Zhang YM; Chen Y; Chen JT; Liu Y
    J Med Chem; 2013 Dec; 56(23):9725-36. PubMed ID: 24252070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives.
    Serrano-Sevilla I; Artiga Á; Mitchell SG; De Matteis L; de la Fuente JM
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31311176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
    Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
    J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.
    Fitzgerald KA; Malhotra M; Gooding M; Sallas F; Evans JC; Darcy R; O'Driscoll CM
    Int J Pharm; 2016 Feb; 499(1-2):131-145. PubMed ID: 26721726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysaccharide-based Noncovalent Assembly for Targeted Delivery of Taxol.
    Yang Y; Zhang YM; Chen Y; Chen JT; Liu Y
    Sci Rep; 2016 Jan; 6():19212. PubMed ID: 26759029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyophilisation and concentration of chitosan/siRNA polyplexes: Influence of buffer composition, oligonucleotide sequence, and hyaluronic acid coating.
    Veilleux D; Gopalakrishna Panicker RK; Chevrier A; Biniecki K; Lavertu M; Buschmann MD
    J Colloid Interface Sci; 2018 Feb; 512():335-345. PubMed ID: 29080529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
    Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH
    J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rigorous control of vesicle-forming lipid pK
    Okamoto A; Koide H; Morita N; Hirai Y; Kawato Y; Egami H; Hamashima Y; Asai T; Dewa T; Oku N
    J Control Release; 2019 Feb; 295():87-92. PubMed ID: 30593831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triblock copolymer-encapsulated nanoparticles with outstanding colloidal stability for siRNA delivery.
    Qian J; Gao X
    ACS Appl Mater Interfaces; 2013 Apr; 5(8):2845-52. PubMed ID: 23320382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles.
    Li Y; Zhang J; Wang B; Shen Y; Ouahab A
    Drug Dev Ind Pharm; 2016; 42(5):737-46. PubMed ID: 26472259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice.
    Yang J; Xie SX; Huang Y; Ling M; Liu J; Ran Y; Wang Y; Thrasher JB; Berkland C; Li B
    Nanomedicine (Lond); 2012 Sep; 7(9):1297-309. PubMed ID: 22583574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.